XML 53 R15.htm IDEA: XBRL DOCUMENT v3.19.3
Share-Based Compensation Plans
 6 Months Ended
Aug. 31, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Share-Based Compensation Plans Share-Based Compensation Plans

We have equity awards outstanding under several share-based compensation plans. During the three and six months ended August 31, 2019, we had the following share-based compensation activity:

•
We issued 1,048 and 2,304 shares to non-employee Board members with a total grant date fair value of $0.1 and $0.2 million, respectively, and share prices of $134.21 and $121.99, respectively.

•
We granted time-vested restricted stock units ("RSUs") that may be settled for 8 and 3,279 shares of common stock, respectively. The RSU grants have a weighted average grant price of $150.86 and $111.51 per share, respectively. For the three months ended August 31, 2019, the total award fair value was insignificant. For the six months ended August 31, 2019, the total award fair value at date of grant was $0.4 million.

•
We granted time-vested restricted stock awards ("RSAs") that may be vested for 4,920 and 45,772 shares of common stock, respectively. The RSA grants have a weighted average grant price of $138.86 and $113.98 per share, respectively, for a total award fair value at date of grant of $0.7 million and $5.2 million, respectively.

•
There were no grants of performance-based stock units ("PSUs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSUs that may be settled for 6,088 shares of common stock. The PSU grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $0.7 million.

•
There were no grants of performance-based restricted stock awards ("PSAs") during the three months ended August 31, 2019. For the six months ended August 31, 2019, we granted PSAs that are targeted to be vested for 122,402 shares of common stock. The PSA grants have a weighted average grant price of $110.85 per share for a total award fair value at date of grant of $13.6 million.

•
RSUs for 3,489 and 66,329 shares vested and settled, respectively, with a total fair value at settlement of $0.5 and $7.6 million and a weighted average share price of $146.26 and $114.58, respectively.  

•
There were no PSUs shares vested and settled during the three months ended August 31, 2019. For the six months ended August 31, 2019, there were 108,572 shares vested and settled with a total fair value at settlement of $14.7 million, and a weighted average share price of $135.85.

•
RSAs for 928 shares vested and settled with a total fair value at settlement of $0.1 million and a weighted average share price of $150.86 during the three and six month periods ended August 31, 2019.
 
•
Employees exercised stock options to purchase 26,368 and 61,765 shares of common stock, respectively.

•
There were no purchases of common stock under the employee stock purchase plan during the three months ended August 31, 2019. For the six months ended August 31, 2019, employees purchased 14,790 shares of common stock under the employee stock purchase plan at an average price of $95.29 per share.

We recorded the following share-based compensation expense in SG&A for the periods shown below: 
 
Three Months Ended August 31,
(in thousands, except per share data)
2019
 
2018
Stock options
$
35

 
$
219

Directors stock compensation
141

 
123

Performance based and other stock awards
6,205

 
4,347

Employee stock purchase plan
—

 
—

Share-based compensation expense
6,381


4,689

Less income tax benefits
(514
)
 
(341
)
Share-based compensation expense, net of income tax benefits
$
5,867


$
4,348

 
 
 
 
Impact of share-based compensation on earnings per share from continuing operations:
 
 
 
Basic
$
0.23

 
$
0.16

Diluted
$
0.23

 
$
0.16


 
Six Months Ended August 31,
(in thousands, except per share data)
2019
 
2018
Stock options
$
151

 
$
527

Directors stock compensation
281

 
246

Performance based and other stock awards
13,228

 
9,918

Employee stock purchase plan
325

 
322

Share-based compensation expense
13,985

 
11,013

Less income tax benefits
(1,091
)
 
(611
)
Share-based compensation expense, net of income tax benefits
$
12,894

 
$
10,402

 
 
 
 
Impact of share-based compensation on earnings per share from continuing operations:
 
 
 
Basic
$
0.51

 
$
0.39

Diluted
$
0.51

 
$
0.39